HIF1A and prostate carcinoma: [29–30] Qian et al. [29] reported that propofol might inhibit prostate cancer progression and metastasis via decreasing HIF-1α expression and reversing hypoxia-induced epithelial-mesenchymal transition by suppressing HIF-1α.